Metrics & MoreArticle Recommendations * sı Supporting Information ABSTRACT: "Spin" has been recently reported as an important degree of electronic freedom to improve the performance of electrocatalysts and photocatalysts. This work demonstrates the manipulations of spin-polarized electrons in CsPbBr 3 halide perovskite nanoplates (NPLs) to boost the photocatalytic CO 2 reduction reaction (CO 2 RR) efficiencies by doping manganese cations (Mn 2+ ) and applying an external magnetic field. Mn-doped CsPbBr 3 (Mn-CsPbBr 3 ) NPLs exhibit an outstanding photocatalytic CO 2 RR compared to pristine CsPbBr 3 NPLs due to creating spinpolarized electrons after Mn doping. Notably, the photocatalytic CO 2 RR of Mn-CsPbBr 3 NPLs is significantly enhanced by applying an external magnetic field. Mn-CsPbBr 3 NPLs exhibit 5.7 times improved performance of photocatalytic CO 2 RR under a magnetic field of 300 mT with a permanent magnet compared to pristine CsPbBr 3 NPLs. The corresponding mechanism is systematically investigated by magnetic circular dichroism spectroscopy, ultrafast transient absorption spectroscopy, and density functional theory simulation. The origin of enhanced photocatalytic CO 2 RR efficiencies of Mn-CsPbBr 3 NPLs is due to the increased number of spin-polarized photoexcited carriers by synergistic doping of the magnetic elements and applying a magnetic field, resulting in prolonged carrier lifetime and suppressed charge recombination. Our result shows that manipulating spin-polarized electrons in photocatalytic semiconductors provides an effective strategy to boost photocatalytic CO 2 RR efficiencies.

Background: Cardiac contractile function requires high energy from mitochondria, and Ca2 + from the sarcoplasmic reticulum (SR). Via local Ca2 + transfer at close mitochondria-SR contacts, cardiac excitation feedforward regulates mitochondrial ATP production to match surges in demand (excitation-bioenergetics coupling). However, pathological stresses may cause mitochondrial Ca2 + overload, excessive reactive oxygen species production and permeability transition, risking homeostatic collapse and myocyte loss. Excitation-bioenergetics coupling involves mitochondria-SR tethers but the role of tethering in cardiac physiology/pathology is debated. Endogenous tether proteins are multifunctional; therefore, nonselective targets to scrutinize interorganelle linkage. Here, we assessed the physiological/pathological relevance of selective chronic enhancement of cardiac mitochondria-SR tethering. Methods: We introduced to mice a cardiac muscle-specific engineered tether (linker) transgene with a fluorescent protein core and deployed 2D/3D electron microscopy, biochemical approaches, fluorescence imaging, in vivo and ex vivo cardiac performance monitoring and stress challenges to characterize the linker phenotype. Results: Expressed in the mature cardiomyocytes, the linker expanded and tightened individual mitochondria-junctional SR contacts; but also evoked a marked remodeling with large dense mitochondrial clusters that excluded dyads. Yet, excitation-bioenergetics coupling remained well-preserved, likely due to more longitudinal mitochondria-dyad contacts and nanotunnelling between mitochondria exposed to junctional SR and those sealed away from junctional SR. Remarkably, the linker decreased female vulnerability to acute massive β-adrenergic stress. It also reduced myocyte death and mitochondrial calcium-overload-associated myocardial impairment in ex vivo ischemia/reperfusion injury. Conclusions: We propose that mitochondria-SR/endoplasmic reticulum contacts operate at a structural optimum. Although acute changes in tethering may cause dysfunction, upon chronic enhancement of contacts from early life, adaptive remodeling of the organelles shifts the system to a new, stable structural optimum. This remodeling balances the individually enhanced mitochondrion-junctional SR crosstalk and excitation-bioenergetics coupling, by increasing the connected mitochondrial pool and, presumably, Ca2 + /reactive oxygen species capacity, which then improves the resilience to stresses associated with dysregulated hyperactive Ca2 + signaling.

Maple syrup urine disease (MSUD) is an inherited error in the metabolism of branched-chain amino acids (BCAAs) caused by a severe deficiency of the branched-chain α-ketoacid dehydrogenase (BCKDH) complex, which ultimately leads to neurological disorders. The limited therapies, including protein-restricted diets and liver transplants, are not as effective as they could be for the treatment of MSUD due to the current lack of molecular insights into the disease pathogenesis. To address this issue, we developed a Drosophila model of MSUD by knocking out the dDBT gene, an ortholog of the human gene encoding the dihydrolipoamide branched chain transacylase (DBT) subunit of BCKDH. The homozygous dDBT mutant larvae recapitulate an array of MSUD phenotypes, including aberrant BCAA accumulation, developmental defects, poor mobile behavior and disrupted L-glutamate homeostasis. Moreover, the dDBT mutation causes neuronal apoptosis during the developmental progression of larval brains. The genetic and functional evidence generated by in vivo depletion of dDBT expression in the eye indicates severe impairment of retinal rhabdomeres. Further, the dDBT mutant shows elevated oxidative stress and higher lipid peroxidation accumulation in the larval brain. Therefore, we conclude from in vivo evidence that the loss of dDBT results in oxidative brain damage that may lead to neuronal cell death and contribute to aspects of MSUD pathology. Importantly, when the dDBT mutants were administrated with Metformin, the aberrances in BCAA levels and motor behavior were ameliorated. This intriguing outcome strongly merits the use of the dDBT mutant as a platform for developing MSUD therapies.This article has an associated First Person interview with the joint first authors of the paper.

RationaleMitochondrial fission and fusion are relatively infrequent in adult cardiomyocytes compared to other cell types. This is surprising considering that proteins involved in mitochondrial dynamics are highly expressed in the heart. It has been previously reported that dynamin related protein 1 (DRP1) has a critical role in mitochondrial fitness and cardiac protection1, 2. Cardiac DRP1 ablation in the adult heart evokes a progressive dilated cardiac myopathy and lethal heart failure. Nevertheless, the conditional cardiacspecific DRP1 knock out animals present a significantly longer survival rate compared with global DRP1 KO models1–3. We have described before the great importance for cardiac physiology of the strategic positioning of mitochondrial proteins in the cardiac tissue4, 5. Therefore, we hypothesize that DRP1 plays a regulatory role in cardiac physiology and mitochondrial fitness by preferentially accumulating at mitochondria and junctional sarcoplasmic reticulum (jSR) contact sites, where the high Ca2+ microdomain is formed during excitation-contraction (EC) coupling.ObjectiveThis study aims to determine whether mitochondria-associated DRP1 is preferentially accumulated in the mitochondria and jSR contact sites and if indeed this is the case, what is the mechanism responsible for such a biased distribution and what is the functional implication.Methods and ResultsUsing high-resolution imaging approaches, we found that mitochondria-associated DRP1 in cardiomyocytes was localized in the discrete regions where T-tubule, jSR, and mitochondria are adjacent to each other. Western blot results showed that mitochondria-bound DRP1 was restricted to the mitochondria-associated membranes (MAM), with undetectable levels in purified mitochondria. Furthermore, in comparison to the cytosolic DRP1, the membrane-bound DRP1 in SR and MAM fractions formed high molecular weight oligomers. In both electrically paced adult cardiomyocytes and Langendorff-perfused beating hearts, the oscillatory Ca2+ pulses preserved MAM-associated DRP1 accumulation. Interestingly, similar to DRP1, all mitochondria-bound β-ACTIN only exists in MAM and not in the purified mitochondria.Additionally, co-immunoprecipitation pulls down both DRP1 and β-ACTIN together. Inhibition of β-ACTIN polymerization with Cytochalasin D disrupts the tight association between DRP1 and β-ACTIN. In cardiac specific DRP1 knockout mouse after 6 weeks of tamoxifen induction the cardiomyocytes show disarray of sarcomere, a decrease of cardiac contraction, loss of mitochondrial membrane potential significantly decreased spare respiratory capacity, and frequent occurrence of earl after contraction, suggesting the heart is susceptible for failure and arrhythmias. Despite of this phenotype, DRP1icKo animal have a longer life spam than other DRP1 KO models. We also observed that DRP1icKO. Strikingly, DRP1 levels are is only modestly decreased in the MAM when compared with the rest of the cellular fractions. These preserved levels were accompanied with preservation of the mitochondrial pool in the MAM fraction obtained from the DRP1icKO hearts.ConclusionsThe results show that in adult cardiomyocytes, mitochondria bound DRP1 clusters in high molecular weight protein complexes at MAM. This clustering is fortified by EC coupling mediated Ca2+ transients and requires its interaction with β-ACTIN. Together with the better preserved DRP1 levels in the DRP1icKO model in the MAM, we conclude that DRP1 is anchored in mitochondria-SR interface through β-ACTIN and position itself to play a fundamental role in regulating mitochondrial quality control in the working heart.